Why PCVX? Vaxcyte, Inc. Analysis, Price & AI Insights | Whystock
PCVX
$56.93+1.24 (+2.23%)
Market OpenUpdated 2:46 PM EDT
Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.